Quantification of matrix metalloproteinase activity in plasma of patients enrolled in a BAY 12-9566 phase I study
Open Access
- 25 January 2001
- journal article
- clinical trial
- Published by Wiley in International Journal of Cancer
- Vol. 91 (6) , 857-862
- https://doi.org/10.1002/1097-0215(200002)9999:9999<::aid-ijc1135>3.0.co;2-m
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Expression of Matrix Metalloproteinase-9 in Squamous Cell Carcinoma of the Uterine Cervix—Clinicopathologic Study Using Immunohistochemistry and mRNAin SituHybridizationGynecologic Oncology, 1999
- Changing views of the role of matrix metalloproteinases in metastasisJNCI Journal of the National Cancer Institute, 1997
- Overexpression of Matrix Metalloproteinase 9 Gene in Hepatocellular Carcinoma With Invasive PotentialHepatology, 1996
- Complex Roles of Matrix Metalloproteinases in Tumor ProgressionPublished by Springer Nature ,1996
- Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic formCancer, 1995
- Expression and in‐situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancerInternational Journal of Cancer, 1995
- Type‐IV collagenase and tissue inhibitor of metalloproteinase in ovarian cancer tissuesInternational Journal of Gynecology & Obstetrics, 1994
- Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasiaBritish Journal of Cancer, 1994
- Activity of type IV collagenases in benign and malignant breast diseaseBritish Journal of Cancer, 1993
- Evaluation of Basement Membrane Components and the 72 kDa Type IV Collagenase in Serous Tumors of the OvaryThe American Journal of Surgical Pathology, 1992